ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 84 filers reported holding ORIC PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $32,158 | -71.4% | 5,642 | -70.5% | 0.00% | – |
| Q4 2022 | $112,499 | +251.6% | 19,100 | +91.0% | 0.00% | – |
| Q3 2022 | $32,000 | -23.8% | 10,000 | +28.2% | 0.00% | – |
| Q1 2022 | $42,000 | -99.4% | 7,800 | -97.7% | 0.00% | -100.0% |
| Q3 2021 | $6,979,000 | -58.2% | 333,782 | -64.6% | 0.03% | -58.7% |
| Q2 2021 | $16,699,000 | -47.0% | 944,001 | -26.6% | 0.08% | -49.0% |
| Q1 2021 | $31,498,000 | – | 1,285,647 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $2,698,000 | 8.92% |
| Column Group LLC | 3,568,181 | $15,985,000 | 3.40% |
| Euclidean Capital LLC | 747,550 | $3,349,000 | 2.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $4,514,000 | 2.72% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,082,304 | $4,849,000 | 1.49% |
| Monaco Asset Management SAM | 364,741 | $1,634,000 | 0.71% |
| EcoR1 Capital, LLC | 3,418,068 | $15,313,000 | 0.53% |
| DAFNA Capital Management LLC | 415,926 | $1,863,000 | 0.51% |
| Boxer Capital, LLC | 1,054,000 | $4,722,000 | 0.30% |
| Casdin Capital, LLC | 601,515 | $2,695,000 | 0.23% |